🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationHas anyone dealt with peptide oxidation and deamidation? Page 4

Has anyone dealt with peptide oxidation and deamidation?

ZaraB_AL Sat, Jan 10, 2026 at 12:20 PM 28 replies 1,096 viewsPage 4 of 6
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jan 10, 2026 at 6:00 PM#16

Just wanted to say — for anyone reading this Has anyone dealt thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

28 17JakeSmashed95, NauseaFreeNow, SteveThurs and 25 others
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Jan 10, 2026 at 6:17 PM#17

ZaraB_AL's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 64 lbs in 9 months.

One thing I would add that ZaraB_AL did not mention: the relationship with food fundamentally changed.

7 16hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 4 others
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Jan 10, 2026 at 6:34 PM#18

Saving this for reference. Quality thread.

14 8robert_kc, dan_philly, MeganSA_TX and 11 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Jan 10, 2026 at 6:51 PM#19

As a healthcare provider, I want to add some clinical context to this discussion on Has anyone dealt with peptide oxidation.

Building on what ZaraB_AL said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Jan 10, 2026 at 8:51 PM
49 0JenMemphis, pat_auckland, Dr.GastroMayo and 46 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jan 10, 2026 at 7:08 PM#20

Subscribing to this thread. Has anyone dealt with is exactly what I've been researching. 🙏

Last edited: Jan 10, 2026 at 11:08 PM
13 13Dr.DermMIA, fiona_VT, denise_HTX and 10 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register